NEW PATH DIAGNOSTICS LLC NPI 1255571428

NPI Details

NEW PATH DIAGNOSTICS LLC is a clinical medical laboratory in Flushing, NY. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. NEW PATH DIAGNOSTICS LLC NPI is 1255571428. The provider is registered as an organization entity type.

The provider's business location address is:

42-11 PARSONS BLVD
GROUND FLOOR
FLUSHING, NY
ZIP 11355-150
Phone: (718) 321-1108
Fax: (718) 321-0158

The provider's authorized official is Jianyou Tan .
The authorized official title is President and has the following contact phone number (718) 321-1108.

The CLIA number assigned to this NPI record is 33D1093401 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Cell examination of urine, computer-assisted (HCPCS:88121)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)

The enumeration date for this NPI number is 3/2/2009 and was last updated on 4/23/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.